| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/08/2012 | CN101670092B 一种注射用促肝细胞生长素冻干粉针剂的制备方法 An injectable preparation pHGF freeze-dried powder |
| 02/08/2012 | CN101632727B 一种中药组合物在制备治疗肺动脉高压的药物中的应用 A Chinese medicinal composition for the preparation of a medicament for the treatment of pulmonary arterial hypertension |
| 02/08/2012 | CN101618141B 一种治疗和预防股骨头缺血性坏死的药物及其制备方法 A medicine for the treatment and prevention of avascular necrosis and its preparation method |
| 02/08/2012 | CN101543582B 一种治疗骨病的中药膏 A method of treating bone disease in the ointment |
| 02/08/2012 | CN101519440B 一种交叉保护性疫苗抗原及其制备方法和应用 One kind of cross-protective vaccine antigen and its preparation method and application |
| 02/08/2012 | CN101384704B 可再吸收的角膜扣状体 Resorbable corneal button-shaped body |
| 02/08/2012 | CN101342238B 一种治疗心脑血管疾病的药物组合物 A method of treating cardiovascular and cerebrovascular diseases, the pharmaceutical composition |
| 02/08/2012 | CN101288758B 一种镇痛药物 One kind of analgesic drugs |
| 02/08/2012 | CN101204402B 一种水蛭的真空冷冻干燥工艺 One kind of vacuum freeze-drying process leech |
| 02/08/2012 | CN101172126B 一种保健美容用中药组合物 A health cosmetic herbal composition |
| 02/07/2012 | US8110399 Isolating nestin-positive stem cells, expanding and translplanting into a patient to replace lost or damaged insulin secreting cells; differentiating pancreatic stem cells to obtain cells that produce insulin and other hormones |
| 02/07/2012 | US8110230 Synergistic phytoceutical compositions |
| 02/07/2012 | US8110227 Dairy based foodstuff containing central nervous system lipids |
| 02/07/2012 | US8110184 Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations |
| 02/07/2012 | US8110180 Method of use of cytokine ZALPHA11 ligand |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | CA2431669C Pesticidal and antiparasitic compositions comprising chitinase or chitin and sulfide |
| 02/07/2012 | CA2423994C Autologous bone graft material |
| 02/07/2012 | CA2383850C Prevention and treatment of mycoplasma-associated diseases |
| 02/07/2012 | CA2382388C Fraction extracted from archaebacteria for cosmetic purposes |
| 02/07/2012 | CA2340863C Thrombin preparations and process for their production |
| 02/02/2012 | WO2012016049A1 Methods for treating and/or reversing neurodegenerative diseases and/or disorders |
| 02/02/2012 | WO2012015486A1 Pairing processes for preparing reactive cytotoxic t cells |
| 02/02/2012 | WO2012015323A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids |
| 02/02/2012 | WO2012014971A1 Lactic bacterium having an effect of ameliorating metabolic syndrome |
| 02/02/2012 | WO2012014247A1 Isolation of pluri potent stem cells from amniotic fluid and use thereof in the treatment or prevention of autoimmune diseases |
| 02/02/2012 | WO2012013862A1 Use of blood group status |
| 02/02/2012 | WO2012013784A1 Regulation of glypican 4 activity to modulate the fate of stem cells and uses thereof |
| 02/02/2012 | WO2012013632A1 Use of anthroposophical remedies for the treatment of alopecia |
| 02/02/2012 | WO2012013344A1 Synthetic synovial fluid compositions and methods for making the same |
| 02/02/2012 | WO2011152566A3 Composition for inducing proliferation or accumulation of regulatory t cells |
| 02/02/2012 | WO2011133040A3 Replication-competent adenoviruses |
| 02/02/2012 | WO2011102680A3 Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway |
| 02/02/2012 | WO2011096728A3 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling |
| 02/02/2012 | US20120029416 Porous electroactive hydrogels and uses thereof |
| 02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 02/02/2012 | US20120028258 Receptor gene screening for detecting or diagnosing cancer |
| 02/02/2012 | US20120027868 Skin care ointment |
| 02/02/2012 | US20120027867 Spray-Dried Blood Products and Methods of Making Same |
| 02/02/2012 | US20120027860 Encapsulated adipose-derived stem cells, methods for preparation and theraputic use |
| 02/02/2012 | US20120027858 Methods and Compositions for Managing Cancer Cell Growth |
| 02/02/2012 | US20120027807 Tissue engineered myocardium and methods of production and uses thereof |
| 02/02/2012 | US20120027804 Medical product, in particular for management of tissue repair |
| 02/02/2012 | US20120027802 Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes |
| 02/02/2012 | US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam |
| 02/02/2012 | US20120027792 Expression vectors able to elicit improved immune response and methods of using same |
| 02/02/2012 | US20120027790 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/02/2012 | US20120027787 Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use |
| 02/02/2012 | US20120027786 Genetically programmable pathogen sense and destroy |
| 02/02/2012 | US20120027740 Method and means for producing tissues and tissues obtained |
| 02/02/2012 | US20120027739 T cell receptors |
| 02/02/2012 | US20120027738 Maternal supplement |
| 02/02/2012 | US20120027737 Use of probiotics to ameliorate diet-induced insulin resistance |
| 02/02/2012 | US20120027736 Anti-obesity agent and anti-obesity food |
| 02/02/2012 | US20120027735 Symbiotic maple product compositions and methods |
| 02/02/2012 | US20120027734 Method for alleviating intestinal problems and novel bacterial strains therefor |
| 02/02/2012 | US20120027733 Compositions to effect neuronal growth |
| 02/02/2012 | US20120027732 Thermoreversible collagen |
| 02/02/2012 | US20120027731 Hemangio-colony forming cells |
| 02/02/2012 | US20120027730 Uses of mesenchymal stem cells |
| 02/02/2012 | US20120027729 Methods for treating diabetes |
| 02/02/2012 | US20120027728 Adjunctive agent for lavaging the alimentary canal comprising butyric acid bacterium and/or lactic acid bacterium |
| 02/02/2012 | US20120027727 Targeted nanoparticles for cancer and other disorders |
| 02/02/2012 | US20120027725 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer |
| 02/02/2012 | US20120027678 Method of using stem cells to aid in diagnosis |
| 02/02/2012 | US20120027676 Modified sodium iodide symporter proteins and uses thereof |
| 02/02/2012 | US20120023677 Composite materials |
| 02/02/2012 | CA2806904A1 Methods for treating and/or reversing neurodegenerative diseases and/or disorders |
| 02/02/2012 | CA2806823A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids |
| 02/02/2012 | CA2806819A1 Regulation of glypican 4 activity to modulate the fate of stem cells and uses thereof |
| 02/01/2012 | EP2412825A1 Leukemia stem cell markers |
| 02/01/2012 | EP2412797A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity |
| 02/01/2012 | EP2412724A1 Regulation of Glypican 4 activity to modulate the fate of stem cells and uses thereof |
| 02/01/2012 | EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 02/01/2012 | EP2411506A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| 02/01/2012 | EP2411042A1 Tissue kallikrein for the treatment of pancreatic -cell dysfunction |
| 02/01/2012 | EP2411034A1 Promotion of neuronal integration in neural stem cell grafts |
| 02/01/2012 | EP2411027A1 Use of a probiotic to regulate body weight |
| 02/01/2012 | EP2411026A1 Use of probiotics to ameliorate diet-induced insulin resistance |
| 02/01/2012 | EP2411025A1 High-temperature stable oxygen-carrier-containing pharmaceutical composition |
| 02/01/2012 | EP2411023A1 Method of tissue repair |
| 02/01/2012 | EP2411006A2 Compositions and methods for treatment of renal disease |
| 02/01/2012 | EP1531840B1 Allomone repulsive compositions for controlling arachnids |
| 02/01/2012 | EP1425390B1 Materials and methods to promote repair of nerve tissue |
| 02/01/2012 | CN1879761B 一种调节机体免疫力、抗突变保健品及其生产方法 A regulator of immunity, anti-mutagenic health products and production methods |
| 02/01/2012 | CN102341113A Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| 02/01/2012 | CN102341112A Method and means for producing tissues and tissues obtained |
| 02/01/2012 | CN102341100A Formulations of viable cells for oral delivery |
| 02/01/2012 | CN102337285A HIhh-containing retrovirus vector and virus particle, and application thereof |
| 02/01/2012 | CN102337246A Development of oligodendrocyte progenitor cells prepared by differentiating mesenchymal stem cells through eleutheroside and kit, and medicine for nerve system disease |
| 02/01/2012 | CN102337244A Dendritic cell loaded with antigen of tumor cell subjected to chemotherapy drug tolerance screening, its preparation method and application |
| 02/01/2012 | CN102337227A Lactobacillus plantarum and purpose thereof |
| 02/01/2012 | CN102337190A Method for making honey health-care wine |
| 02/01/2012 | CN102336821A New Melan-A epitope peptide and application thereof in preventing and/or treating tumours |
| 02/01/2012 | CN102335457A Composition for tooth regeneration |
| 02/01/2012 | CN102335439A HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 02/01/2012 | CN102335438A Application of recombinant plasmid containing HIPK2 (homedomain interacting protein kinase 2) gene for preparing anti-tumor medicaments |
| 02/01/2012 | CN102335427A Application of signal regulatory protein alpha to preparation of macrophages for preventing and treating tumors |
| 02/01/2012 | CN102335418A Health-care wine for relieving rheumatoid swelling |
| 02/01/2012 | CN102335417A Health-care product for restoring physical strength in later period of cold |